Opill (norgestrel)

Oral contraceptive pills have been a cornerstone of contraception for more than 6 decades. Oral contraceptives are highly effective in preventing unintended pregnancy, making them the most utilized reversible contraceptive method. Daily oral contraceptive pills have traditionally required a prescription from a healthcare provider due to potential risks and adverse reactions associated with use. The need for prescription creates significant barriers to accessibility and convenience for patients who may resort to less effective but more readily available nonprescription methods. Opill® (norgestrel) is the first and only FDA-approved daily oral contraceptive for over-the-counter use. This article examines Opill's place in the current US contraceptive market.

Authors

Institutions

Publication Details

Journal
JAAPA
Published
2025-05-27
DOI
https://doi.org/10.1097/01.jaa.0000000000000209
Citations
1
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
1.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Opill (norgestrel)

Jolene Bohensky, Nicole Daher
1 citations
JAAPA
Reproductive Health and Contraception
1.88
article

Opill (norgestrel)

Jolene Bohensky, Nicole Daher
article en
1 citations

Abstract

Oral contraceptive pills have been a cornerstone of contraception for more than 6 decades. Oral contraceptives are highly effective in preventing unintended pregnancy, making them the most utilized reversible contraceptive method. Daily oral contraceptive pills have traditionally required a prescription from a healthcare provider due to potential risks and adverse reactions associated with use. The need for prescription creates significant barriers to accessibility and convenience for patients who may resort to less effective but more readily available nonprescription methods. Opill® (norgestrel) is the first and only FDA-approved daily oral contraceptive for over-the-counter use. This article examines Opill's place in the current US contraceptive market.

JAAPAVol. 38(6)
Philadelphia College of Osteopathic Medicine (US)
Good health and well-being
Openalex Percentile: Top 15%
Reproductive Health and Contraception
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.